• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立用于预测胃癌患者根治性胃切除术后早期和晚期复发预后的列线图。

Defining nomograms for predicting prognosis of early and late recurrence in gastric cancer patients after radical gastrectomy.

机构信息

Department of General Surgery, Shaoxing People's Hospital, Shaoxing, China.

Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Medicine (Baltimore). 2023 Oct 20;102(42):e35585. doi: 10.1097/MD.0000000000035585.

DOI:10.1097/MD.0000000000035585
PMID:37861478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10589600/
Abstract

There are few studies on the predictive factors of early recurrence (ER) and late recurrence (LR) of advanced gastric cancer (GC) after curative surgery. Our study aims to explore the independent predictors influencing the prognosis between ER and LR in patients with advanced GC after curative intent surgery respectively. And we will further develop nomograms for prediction of post recurrence survival (PRS). Data of patients with GC who received radical gastrectomy was retrospectively collected. Recurrence was classified into ER and LR according to the 2 years after surgery as the cutoff value. Multivariate Cox regression analyses were used to explore significant predictors in our analysis. Then these significant predictors were integrated to construct nomograms. The 1-, 2- and 3-year probabilities of PRS in patients with ER were 30.00%, 16.36% and 11.82%, respectively. In contrast, the late group were 44.68%, 23.40%, and 23.30%, respectively. Low body mass index (hazard ratio [HR] = 0.86, P = .001), elevated monocytes count (HR = 4.54, P = .003) and neutrophil-lymphocyte ratio (HR = 1.03, P = .037) at the time of recurrence were risk factors of PRS after ER. Decreased hemoglobin (HR = 0.97, P = .008) and elevated neutrophil-lymphocyte ratio (HR = 1.06, P = .045) at the time of recurrence were risk factors of PRS after LR. The calibration curves for probability of 1-, 2-, and 3-year PRS showed excellent predictive effect. Internal validation concordance indexes of PRS were 0.722 and 0.671 for ER and LR respectively. In view of the different predictive factors of ER and LR of GC, the practical predictive model may help clinicians make reasonable decisions.

摘要

根治性手术后,关于晚期胃癌(GC)早期复发(ER)和晚期复发(LR)的预测因素的研究较少。我们的研究旨在分别探讨影响根治术后晚期 GC 患者 ER 和 LR 预后的独立预测因素,并进一步建立预测复发后生存(PRS)的列线图。回顾性收集接受根治性胃切除术的 GC 患者的数据。根据术后 2 年作为截点,将复发分为 ER 和 LR。多变量 Cox 回归分析用于探讨分析中的显著预测因子。然后将这些显著预测因子整合到列线图中。ER 患者的 1 年、2 年和 3 年 PRS 概率分别为 30.00%、16.36%和 11.82%。相比之下,晚期组分别为 44.68%、23.40%和 23.30%。复发时低体重指数(风险比 [HR] = 0.86,P =.001)、升高的单核细胞计数(HR = 4.54,P =.003)和中性粒细胞-淋巴细胞比值(HR = 1.03,P =.037)是 ER 后 PRS 的危险因素。复发时血红蛋白降低(HR = 0.97,P =.008)和中性粒细胞-淋巴细胞比值升高(HR = 1.06,P =.045)是 LR 后 PRS 的危险因素。1 年、2 年和 3 年 PRS 概率的校准曲线显示出良好的预测效果。ER 和 LR 的 PRS 的内部验证一致性指数分别为 0.722 和 0.671。鉴于 GC 的 ER 和 LR 的预测因素不同,实用的预测模型可能有助于临床医生做出合理的决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/8bcc8c1318e1/medi-102-e35585-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/d84ba12b81f2/medi-102-e35585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/3f85d1b77144/medi-102-e35585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/ff3460c1ca86/medi-102-e35585-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/c840e3c818c2/medi-102-e35585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/8bcc8c1318e1/medi-102-e35585-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/d84ba12b81f2/medi-102-e35585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/3f85d1b77144/medi-102-e35585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/ff3460c1ca86/medi-102-e35585-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/c840e3c818c2/medi-102-e35585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a95/10589600/8bcc8c1318e1/medi-102-e35585-g005.jpg

相似文献

1
Defining nomograms for predicting prognosis of early and late recurrence in gastric cancer patients after radical gastrectomy.建立用于预测胃癌患者根治性胃切除术后早期和晚期复发预后的列线图。
Medicine (Baltimore). 2023 Oct 20;102(42):e35585. doi: 10.1097/MD.0000000000035585.
2
Development and validation of nomograms for predicting the prognosis of early and late recurrence of advanced gastric cancer after radical surgery based on post-recurrence survival.基于复发后生存情况,建立并验证用于预测根治术后晚期及早期复发的进展期胃癌患者预后的列线图。
Medicine (Baltimore). 2024 May 31;103(22):e38376. doi: 10.1097/MD.0000000000038376.
3
Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer.开发和验证用于预测 II/III 期胃癌根治性切除术后早期复发的预后列线图。
World J Surg Oncol. 2019 Dec 19;17(1):223. doi: 10.1186/s12957-019-1750-1.
4
Defining a Nomogram for Predicting Early Recurrence in Gastric Cancer Patients After Neoadjuvant Chemotherapy and Radical Gastrectomy.定义用于预测新辅助化疗和根治性胃切除术后胃癌患者早期复发的列线图。
J Gastrointest Surg. 2023 Sep;27(9):1766-1777. doi: 10.1007/s11605-023-05697-7. Epub 2023 May 23.
5
[Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].[伴有神经侵犯的进展期胃癌预测列线图模型的建立与验证]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004.
6
Evaluation and validation of the prognostic value of nutrition and immunity parameters in gastric cancer after R0 resection.R0切除术后胃癌营养与免疫参数预后价值的评估与验证
Medicine (Baltimore). 2020 Feb;99(8):e19270. doi: 10.1097/MD.0000000000019270.
7
Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.基于肿瘤相关中性粒细胞与淋巴细胞比值的列线图预测胃神经内分泌肿瘤患者的生存情况。
World J Gastroenterol. 2017 Dec 21;23(47):8376-8386. doi: 10.3748/wjg.v23.i47.8376.
8
[Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].[包含术前炎症反应和营养指标的预测模型对胃癌患者的预后价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Jul 25;26(7):680-688. doi: 10.3760/cma.j.cn441530-20221018-00415.
9
Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.预测根治性肝切除术后肝细胞癌早期和晚期复发的新型预后列线图
Cancer Manag Res. 2020 Mar 9;12:1693-1712. doi: 10.2147/CMAR.S241959. eCollection 2020.
10
Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma.胃腺癌根治性手术后的早期复发。
Ann Surg Oncol. 2022 Dec;29(13):8653-8661. doi: 10.1245/s10434-022-12434-y. Epub 2022 Aug 26.

引用本文的文献

1
The efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone in advanced or metastatic gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials.PD-1/PD-L1抑制剂联合化疗与单纯化疗治疗晚期或转移性胃癌或胃食管交界癌的疗效和安全性:一项随机对照试验的荟萃分析
Eur J Clin Pharmacol. 2025 Jun 10. doi: 10.1007/s00228-025-03861-3.
2
Integrating Mendelian randomization and multi-transcriptomic analyses to unveil the genetic association risk of regulatory T cell-mediated free cholesterol and gastric cancer.整合孟德尔随机化和多转录组分析以揭示调节性T细胞介导的游离胆固醇与胃癌的遗传关联风险
Discov Oncol. 2025 May 22;16(1):864. doi: 10.1007/s12672-025-02739-1.
3
Meta-analysis of the efficacy of applying reduced surgery for the treatment of asymptomatic unresectable advanced gastric cancer.
应用缩小手术治疗无症状不可切除进展期胃癌疗效的Meta分析。
BMC Gastroenterol. 2025 Apr 18;25(1):271. doi: 10.1186/s12876-025-03849-4.
4
Development and verification of a radiomics model to forecast Ki67 index and prognosis in advanced gastric tubular adenocarcinoma.预测进展期胃管状腺癌Ki67指数及预后的影像组学模型的开发与验证
BMC Gastroenterol. 2025 Apr 15;25(1):260. doi: 10.1186/s12876-025-03845-8.
5
Comparative study of XGBoost and logistic regression for predicting sarcopenia in postsurgical gastric cancer patients.XGBoost与逻辑回归用于预测胃癌术后患者肌肉减少症的比较研究
Sci Rep. 2025 Apr 14;15(1):12808. doi: 10.1038/s41598-025-98075-z.
6
Machine Learning Prediction of Early Recurrence in Gastric Cancer: A Nationwide Real-World Study.机器学习预测胃癌早期复发:一项全国性真实世界研究。
Ann Surg Oncol. 2025 Apr;32(4):2637-2650. doi: 10.1245/s10434-024-16701-y. Epub 2024 Dec 30.
7
Exploring Individualized Follow-up of Gastric Cancer After Radical Surgery Based on pTNM Stage: A Retrospective Cohort Study From China.基于pTNM分期的胃癌根治术后个体化随访研究:一项来自中国的回顾性队列研究
Clin Med Insights Oncol. 2024 Sep 3;18:11795549241272654. doi: 10.1177/11795549241272654. eCollection 2024.
8
Role of Recurrence Pattern Multiplicity in Predicting Post-recurrence Survival in Patients Who Underwent Curative Gastrectomy for Gastric Cancer.复发模式多样性在预测接受胃癌根治性胃切除术患者复发后生存中的作用
J Gastric Cancer. 2024 Apr;24(2):231-242. doi: 10.5230/jgc.2024.24.e18.